C166H203BrClN37O13 — CID 159898777
(2R)-4-[(4-acetamidophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-bromophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-chlorophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexyl-4-[[4-(dimethylamino)phenyl]methyl]piperazine-1,2-dicarboxamide;methyl 4-[[(3R)-3-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethylcarbamoyl]-4-(cyclohexylcarbamoyl)piperazin-1-yl]methyl]benzoate (PubChem CID 159898777) has the molecular formula C166H203BrClN37O13 and a molecular weight of 3040.05 g/mol. Its IUPAC name is (2R)-4-[(4-acetamidophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-bromophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-chlorophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexyl-4-[[4-(dimethylamino)phenyl]methyl]piperazine-1,2-dicarboxamide;methyl 4-[[(3R)-3-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethylcarbamoyl]-4-(cyclohexylcarbamoyl)piperazin-1-yl]methyl]benzoate.
| Compound Name | (2R)-4-[(4-acetamidophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-bromophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-chlorophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexyl-4-[[4-(dimethylamino)phenyl]methyl]piperazine-1,2-dicarboxamide;methyl 4-[[(3R)-3-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethylcarbamoyl]-4-(cyclohexylcarbamoyl)piperazin-1-yl]methyl]benzoate |
|---|---|
| PubChem CID | 159898777 |
| Molecular Formula | C166H203BrClN37O13 |
| Molecular Weight | 3040.05 g/mol |
| Exact Mass | 3036.52 |
| IUPAC Name | (2R)-4-[(4-acetamidophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-bromophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-4-[(4-chlorophenyl)methyl]-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexylpiperazine-1,2-dicarboxamide;(2R)-2-N-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethyl]-1-N-cyclohexyl-4-[[4-(dimethylamino)phenyl]methyl]piperazine-1,2-dicarboxamide;methyl 4-[[(3R)-3-[2-[3-[(4-cyanophenyl)methyl]imidazol-4-yl]ethylcarbamoyl]-4-(cyclohexylcarbamoyl)piperazin-1-yl]methyl]benzoate |
| SMILES | CC(=O)Nc1ccc(CN2CCN(C(=O)NC3CCCCC3)[C@@H](C(=O)NCCc3cncn3Cc3ccc(C#N)cc3)C2)cc1.CN(C)c1ccc(CN2CCN(C(=O)NC3CCCCC3)[C@@H](C(=O)NCCc3cncn3Cc3ccc(C#N)cc3)C2)cc1.COC(=O)c1ccc(CN2CCN(C(=O)NC3CCCCC3)[C@@H](C(=O)NCCc3cncn3Cc3ccc(C#N)cc3)C2)cc1.N#Cc1ccc(Cn2cncc2CCNC(=O)[C@H]2CN(Cc3ccc(Br)cc3)CCN2C(=O)NC2CCCCC2)cc1.N#Cc1ccc(Cn2cncc2CCNC(=O)[C@H]2CN(Cc3ccc(Cl)cc3)CCN2C(=O)NC2CCCCC2)cc1 |
| InChI | InChI=1S/C34H42N8O3.C34H44N8O2.C34H41N7O4.C32H38BrN7O2.C32H38ClN7O2/c1-25(43)38-30-13-11-27(12-14-30)21-40-17-18-42(34(45)39-29-5-3-2-4-6-29)32(23-40)33(44)37-16-15-31-20-36-24-41(31)22-28-9-7-26(19-35)8-10-28;1-39(2)30-14-12-27(13-15-30)22-40-18-19-42(34(44)38-29-6-4-3-5-7-29)32(24-40)33(43)37-17-16-31-21-36-25-41(31)23-28-10-8-26(20-35)9-11-28;1-45-33(43)28-13-11-26(12-14-28)21-39-17-18-41(34(44)38-29-5-3-2-4-6-29)31(23-39)32(42)37-16-15-30-20-36-24-40(30)22-27-9-7-25(19-35)8-10-27;2*33-27-12-10-25(11-13-27)20-38-16-17-40(32(42)37-28-4-2-1-3-5-28)30(22-38)31(41)36-15-14-29-19-35-23-39(29)21-26-8-6-24(18-34)7-9-26/h7-14,20,24,29,32H,2-6,15-18,21-23H2,1H3,(H,37,44)(H,38,43)(H,39,45);8-15,21,25,29,32H,3-7,16-19,22-24H2,1-2H3,(H,37,43)(H,38,44);7-14,20,24,29,31H,2-6,15-18,21-23H2,1H3,(H,37,42)(H,38,44);2*6-13,19,23,28,30H,1-5,14-17,20-22H2,(H,36,41)(H,37,42)/t2*32-;31-;2*30-/m11111/s1 |
| InChIKey | NVRKQQDRWKNRRR-LFQRIBOLSA-N |
| XLogP | 19.68 |
| TPSA | 590.09 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 218 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3040.05 |
| LogP ≤ 5 | 19.68 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 34 |
| Structural Alerts | {'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'} |
|---|